17 April 2024
Pharmaceuticals | Top 5 Selected Papers in 2022–2023 in the Section “Biopharmaceuticals”

  1. “Cyclic Peptides in Pipeline: What Future for These Great Molecules?”
    by Lia Costa, Emília Sousa and Carla Fernandes
    Pharmaceuticals 2023, 16(7), 996; https://doi.org/10.3390/ph16070996
    Available online: https://www.mdpi.com/1424-8247/16/7/996
  1. “Potential of Lactoferrin in the Treatment of Lung Diseases”
    by Katarzyna Kaczyńska, Monika Jampolska, Piotr Wojciechowski, Dorota Sulejczak, Kryspin Andrzejewski and Dominika Zając
    Pharmaceuticals 2023, 16(2), 192; https://doi.org/10.3390/ph16020192
    Available online: https://www.mdpi.com/1424-8247/16/2/192
  1. “Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study”
    by Ana Batinic, Davorka Sutlović, Sendi Kuret, Antonela Matana, Marko Kumric, Josko Bozic and Zeljko Dujic
    Pharmaceuticals 2023, 16(5), 645; https://doi.org/10.3390/ph16050645
    Available online: https://www.mdpi.com/1424-8247/16/5/645
  1. “MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway”
    by Massimo Moro, Orazio Fortunato, Giulia Bertolini, Mavis Mensah, Cristina Borzi, Giovanni Centonze, Francesca Andriani, Daniela Di Paolo, Patrizia Perri, Mirco Ponzoni et al.
    Pharmaceuticals 2022, 15(3), 297; https://doi.org/10.3390/ph15030297
    Available online: https://www.mdpi.com/1424-8247/15/3/297
  1. “Strategies for Improving Peptide Stability and Delivery”
    by Othman Al Musaimi, Lucia Lombardi, Daryl R. Williams and Fernando Albericio
    Pharmaceuticals 2022, 15(10), 1283; https://doi.org/10.3390/ph15101283
    Available online: https://www.mdpi.com/1424-8247/15/10/1283

Back to TopTop